Martin A Kabelitz, Lisa Sandmann, Michael Praktiknjo, Jim B Mauz, Timo Alexander Auer, Tony Bruns, Johannes Chang, Uli Fehrenbach, Jan Hinrichs, Christian Jansen, Roman Klöckner, Johannes Kluwe, Michael Köhler, Carsten Meyer, Felix Piecha, Maike Rebecca Pollmanns, Cristina Ripoll, Michael Schultheiss, Leon Louis Seifert, Fabian Stöhr, Lukas Sturm, Jonel Trebicka, Alexander Zipprich, Christian Labenz, Dominik Bettinger, Benjamin Maasoumy
{"title":"Early occurrence of hepatic encephalopathy following TIPS-insertion is linked to impaired survival: a multicenter cohort study.","authors":"Martin A Kabelitz, Lisa Sandmann, Michael Praktiknjo, Jim B Mauz, Timo Alexander Auer, Tony Bruns, Johannes Chang, Uli Fehrenbach, Jan Hinrichs, Christian Jansen, Roman Klöckner, Johannes Kluwe, Michael Köhler, Carsten Meyer, Felix Piecha, Maike Rebecca Pollmanns, Cristina Ripoll, Michael Schultheiss, Leon Louis Seifert, Fabian Stöhr, Lukas Sturm, Jonel Trebicka, Alexander Zipprich, Christian Labenz, Dominik Bettinger, Benjamin Maasoumy","doi":"10.1016/j.cgh.2025.01.024","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and aims: </strong>Hepatic encephalopathy (HE) is a common complication following transjugular intrahepatic portosystemic shunt (TIPS) insertion. However, the prognostic significance of overt HE post-TIPS remains controversial.</p><p><strong>Methods: </strong>We screened 2137 patients who underwent TIPS insertion at eight German tertiary care centers between 2004 and 2021. Patients with pre-emptive TIPS placement, hepatocellular carcinoma, missing data, and non-PTFE covered stents were excluded. Competing risk analysis was performed, considering liver transplantation as a competing event. To correct for immortal time bias, landmark analyses were conducted, with the landmark being set at 30 and 90-days post-TIPS. Outcome data were assessed for up to 30 months post-TIPS insertion.</p><p><strong>Results: </strong>A total of 1356 patients (median MELD: 13 (IQR 10-17), age: 60 (IQR 54-67), 64% male, 12% HE before TIPS), were included. Overall, HE post-TIPS was linked to impaired survival (p<0.001, sHR: 1.41 [1.15-1.73]). However, this was only confirmed if HE occurred within the first 30 days post-TIPS (early HE; p<0.001, sHR: 2.02 [1.59-2.57]). Additionally, patients with a history of HE (p<0.001, sHR: 1.59 [1.21-2.07]) and history of HE and early HE post-TIPS (p<0.001, sHR: 3.44 [2.34-5.04]) showed impaired survival. These findings were confirmed in the landmark and multivariable analyses.</p><p><strong>Conclusion: </strong>Early HE post-TIPS is associated with significantly reduced survival. Therefore, patients who experience early HE or have a history of HE should be closely monitored by physicians, as they constitute a particularly vulnerable group with impaired survival.</p>","PeriodicalId":10347,"journal":{"name":"Clinical Gastroenterology and Hepatology","volume":" ","pages":""},"PeriodicalIF":11.6000,"publicationDate":"2025-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Gastroenterology and Hepatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.cgh.2025.01.024","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background and aims: Hepatic encephalopathy (HE) is a common complication following transjugular intrahepatic portosystemic shunt (TIPS) insertion. However, the prognostic significance of overt HE post-TIPS remains controversial.
Methods: We screened 2137 patients who underwent TIPS insertion at eight German tertiary care centers between 2004 and 2021. Patients with pre-emptive TIPS placement, hepatocellular carcinoma, missing data, and non-PTFE covered stents were excluded. Competing risk analysis was performed, considering liver transplantation as a competing event. To correct for immortal time bias, landmark analyses were conducted, with the landmark being set at 30 and 90-days post-TIPS. Outcome data were assessed for up to 30 months post-TIPS insertion.
Results: A total of 1356 patients (median MELD: 13 (IQR 10-17), age: 60 (IQR 54-67), 64% male, 12% HE before TIPS), were included. Overall, HE post-TIPS was linked to impaired survival (p<0.001, sHR: 1.41 [1.15-1.73]). However, this was only confirmed if HE occurred within the first 30 days post-TIPS (early HE; p<0.001, sHR: 2.02 [1.59-2.57]). Additionally, patients with a history of HE (p<0.001, sHR: 1.59 [1.21-2.07]) and history of HE and early HE post-TIPS (p<0.001, sHR: 3.44 [2.34-5.04]) showed impaired survival. These findings were confirmed in the landmark and multivariable analyses.
Conclusion: Early HE post-TIPS is associated with significantly reduced survival. Therefore, patients who experience early HE or have a history of HE should be closely monitored by physicians, as they constitute a particularly vulnerable group with impaired survival.
期刊介绍:
Clinical Gastroenterology and Hepatology (CGH) is dedicated to offering readers a comprehensive exploration of themes in clinical gastroenterology and hepatology. Encompassing diagnostic, endoscopic, interventional, and therapeutic advances, the journal covers areas such as cancer, inflammatory diseases, functional gastrointestinal disorders, nutrition, absorption, and secretion.
As a peer-reviewed publication, CGH features original articles and scholarly reviews, ensuring immediate relevance to the practice of gastroenterology and hepatology. Beyond peer-reviewed content, the journal includes invited key reviews and articles on endoscopy/practice-based technology, health-care policy, and practice management. Multimedia elements, including images, video abstracts, and podcasts, enhance the reader's experience. CGH remains actively engaged with its audience through updates and commentary shared via platforms such as Facebook and Twitter.